BioXcel Therapeutics (BTAIQ) EBIT Margin (2022 - 2026)
BioXcel Therapeutics' EBIT Margin was -5600.55% in Q2 2026, up 7609.45 percentage points from -13210.00% a year earlier but down 637.93 percentage points from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) EBIT Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioXcel Therapeutics' EBIT Margin was -6054.72% through Jun 30, 2026, down 94.23 percentage points year-over-year; for FY2025, it was -7859.97%, down 4892.40 percentage points from FY2024.
- EBIT Margin shows a three-year change of +34712.03 percentage points (FY2022 to FY2025).
- In earlier years, EBIT Margin was -2967.56% in FY2024 (+9480.41 pp), -12447.97% in FY2023 (+30124.03 pp) and -42572.00% in FY2022.
- Quarterly EBIT Margin has moved between -28459.85% (Q3 2022) and -1566.67% (Q2 2024) over five years.
- Compared with a year earlier, EBIT Margin was higher in four of the last eight quarters, with an average year-over-year change of -491.29 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q1 2024 (a gain of 20701.68 percentage points); the worst was Q2 2025 (a drop of 11643.33 percentage points).
- Per Business Quant data, BTAIQ's EBIT Margin in the three quarters before Q2 2026 was -4962.62% (Q1 2026), -4016.41% (Q4 2025) and -14518.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | -5,600.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,600.55% |
| Mar 31, 2026 | -4,962.62% |
| Dec 31, 2025 | -4,016.41% |
| Sep 30, 2025 | -14,518.37% |
| Jun 30, 2025 | -13,210.00% |
| Mar 31, 2025 | -6,011.31% |
| Dec 31, 2024 | -2,866.94% |
| Sep 30, 2024 | -7,146.26% |
| Jun 30, 2024 | -1,566.67% |
| Mar 31, 2024 | -4,151.72% |
| Dec 31, 2023 | -5,285.90% |
| Sep 30, 2023 | -14,163.34% |
| Jun 30, 2023 | -11,469.15% |
| Mar 31, 2023 | -24,853.40% |
| Dec 31, 2022 | -22,224.37% |
| Sep 30, 2022 | -28,459.85% |
API Access
BioXcel Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();